How to Cite
Abstract
Objective: This research aims to explore the connection between the gut microbiome and neurodegenerative diseases, particularly Alzheimer's and Parkinson's. The objective is to understand how gut health influences neuroinflammation and disease progression, potentially opening new avenues for therapeutic interventions.
Methods:
The study was carried out at a tertiary care medical center in Punjab, Pakistan. A multidisciplinary approach integrating microbiological analysis, neurological assessment, inflammatory biomarker profiling, and neuroimaging data was employed. Gut microbiota composition was analyzed using stool samples, while neurodegenerative status was evaluated through standardized clinical scales and laboratory markers of neuroinflammation. Correlations between microbial dysbiosis, systemic inflammation, and neurological impairment were examined.
Results:
The findings demonstrated a significant association between gut microbiome imbalance and increased neuroinflammatory markers in patients with Alzheimer’s and Parkinson’s diseases. Reduced microbial diversity and an overrepresentation of pro-inflammatory bacterial taxa were observed. These changes were linked to elevated cytokine levels, compromised intestinal barrier integrity, and accelerated neurodegenerative progression. The results suggested that gut-derived inflammatory signals played a substantial role in modulating brain pathology.
Conclusion:
This research concluded that the gut–brain axis had a critical influence on neurodegenerative disease mechanisms. Modulation of the gut microbiome emerged as a promising therapeutic target for slowing disease progression and improving neurological outcomes. The study provided foundational evidence supporting microbiota-based interventions as adjunct strategies in the management of neurodegenerative disorders.